Experimental ‘preemptive’ therapy fails to improve autism traits in study

new dads x
Image: Kaiser Permanente

An experimental behavioral therapy delivered by parents does not improve autism traits in babies who screen positive for the condition, according to a new study.

The results are disappointing, say independent experts, because they had high hopes for this particular approach’s promise in mitigating the severity of autism traits.

The researchers started babies on the therapy between 9 and 14 months of age. Six months later, according to parent reports, the children who received the therapy spoke and understood more words than those who did not. But when the researchers evaluated the same children, they did not detect a statistically significant difference between the two groups.

It’s unclear why the treatment had limited success in this case, [psychology professor Connie Kasari] says, but it’s unlikely that any single strategy would work for all families. She argues for a personalized approach to early intervention. “We really need to rethink preemptive interventions for kids at risk [of autism],” she says.

The researchers are following the children in the study to assess whether their improvements persist. They also plan to test whether the therapy decreases a child’s chances of an autism diagnosis or eases autism traits at age 3.

Read full, original post: Test of ‘preemptive’ autism therapy detects few benefits

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image Jun 3, 2026, 03_14_43 PM
Viewpoint: How Earthjustice became the poster child for the abuse of special interest activist funding
ChatGPT Image Jun 3, 2026, 03_54_37 PM
Viewpoint: “Turn on, tune in, drop out”—Kennedy embraces the Timothy Leary psychedelic revolution
ChatGPT-Image-Jun-11-2026-01_15_03-PM
Selective Pressure, Selective Silence
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.